期刊文献+

胃癌易感性与细胞毒性T淋巴细胞相关抗原-4基因+49A/G多态性的关系 被引量:4

Association of cytotoxic T lymphocyte antigen-4 gene + 49 A/G polymorphism with susceptibility of gastric cancer
原文传递
导出
摘要 目的探讨细胞毒性T淋巴细胞相关抗原-4(CTLA-4)基因外显子1区+49A/G位点多态性在中国人群中的分布及其与胃癌易感性的关系。方法应用聚合酶链反应-限制性片段长度多态性(PCR—RFLP)方法检测205例胃癌患者和262例正常对照者CTLA-4基因+49A/G多态位点基因型频率,进行多态性与胃癌易感性的关系分析并进行分层分析。结果CTLA-4基因外显子1区+49位点A/G、G/G基因型在胃癌组患者中的分布频率明显高于对照组(P〈0.01,OR=2.146;P〈0.01,OR=3.215);分层分析示:男性患者、年龄在40~55岁之间、不吸烟、不饮酒患者组等组别的胃癌患者携带G/G基因型的频率较正常对照组显著增加。结论CTLA-4基因外显子1区+49A/G多态性与胃癌易感性有明显相关,携带A/G、G/G基因型的个体胃癌发病风险增加,分层因素也影响这一结果。 Objective To investigate the distribution of +49A/G polymorphism of CTLA-4 gene in Chinese population and the association between the polymorphism and susceptibility of gastric cancer. Methods Unrelated 205 patients with gastric cancer and 262 healthy controls were enrolled, polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used to determine genotype frequencies of + 49A/G polymorphism. The association of the polymorphism with relevant risk factors of gastrie cancer was analyzed. Results The distribution of + 49A/G gene polymorphism was in accordance with Hardy-Weinberg equilibrium. The A/G and G/G genotype frequencies in the patients were significantly higher than those in controls ( P 〈 0.01, OR = 2. 146 ; P 〈 0.01, OR = 3. 215 ) ; Stratified by clinical characters : men, or age between 40 and 55, or without smoking or drinking in patients with gastric cancer carried more G/G genotype than the controls. Conclusion CTLA-4 + 49A/G polymorphism might be a predisposing factor of gastric cancer.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2009年第6期747-749,共3页 Chinese Journal of Experimental Surgery
关键词 细胞毒性T淋巴细胞相关抗原-4 基因多态性 胃癌 易感性 Cytotoxic T lymphocyte-associated antigen-4 Gene polymorphism Gastric carcinoma Susceptibility
  • 相关文献

参考文献6

  • 1Chen L, Ashe S, Brady WA, et al. Costimulation of antitumor immunity by the B7 counterreceptor for the Tlymphocyte molecules CD28 and CTLA4. Cell, 1992,71 : 1093-1102.
  • 2Hodi FS, Butler M, Oble DA, et al. Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients. Proc Natl Acad Sci USA ,2008, 105:3005-3010.
  • 3Kouki T, Sawai Y, Gardine CA, et al. CTLA-4 gene polyrnorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol,2000, 165:6606-6611.
  • 4Hadinia A, Hossieni SV, Erfani N, et al. CTLA4 gene promoter and exon 1 polymorphisms in Iranian patients with gastric and colorectal cancers. J Gastroenterol Hepatol, 2007,22 : 2283-2287.
  • 5宋继权,夏冰,李睿,李春,吴云华.胃癌与细胞毒性T淋巴细胞相关抗原-4基因启动子区域多态性的相关性研究[J].中华实验外科杂志,2006,23(11):1373-1374. 被引量:8
  • 6杨维良,张新晨.胃癌基因治疗的现状及展望[J].中华实验外科杂志,2004,21(5):639-640. 被引量:11

二级参考文献5

  • 1Hudson LL, Rocca K, Song YW, et al. CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant asso2ciation with a determinant in the promoter region. Hum Genet,2002,111:452-455.
  • 2Ogawa S, Nitta K,Hara Y, et al. CD28 knockout mice as a uselul clue to examine the pathogenesis of chronic graft-versus-host reaction. Kidney Int,2000,58:2215-2220.
  • 3Shaw G, Kamen R. A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell,1986,46:659-667.
  • 4Ligers A, Teleshova N, Masterman T, et al. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun,2001,2:145-152.
  • 5Richard Essner M.D.,Yozmg Hzlynh B.S.,Tung Ngtiyen B.S.,D. Michael Rose M.D.,Masayuki Kojinza M.D.,Dave S. B. Hoon Ph.D.. Functional interleukin-4 receptor and interleukin-2 receptor common gamma chain in human gastric carcinoma: a possible mechanism for cytokine-based therapy[J] 2001,Journal of Gastrointestinal Surgery(1):81~90

共引文献17

同被引文献21

  • 1毛海婷,王雄彪,张玲,顾洪涛.CTLA-4基因多态性在重症肌无力发病机理中的作用[J].中华医学遗传学杂志,2004,21(6):574-578. 被引量:13
  • 2宋继权,夏冰,李睿,李春,吴云华.胃癌与细胞毒性T淋巴细胞相关抗原-4基因启动子区域多态性的相关性研究[J].中华实验外科杂志,2006,23(11):1373-1374. 被引量:8
  • 3Kimura H, Kato Y, Shimizu S, et al. Association of polymorphism at position 49 in c'xon 1 of the cytotoxic T-lymphocyte-associated factor 4 gene with Graves' disease refractory to medical treatment, but not with amiodarone-associated thyroid dysfunction [J]. Thyroid, 2009, 19(9) :975 -781.
  • 4Pincerati MR, Dalla-Costa R, Pavoni DP, et al. Genetic polymorphisms of the T-cell coreceptors CD28 and CTLA-4 in Afro- and Euro-Brazilians[ J]. J Immunol,2010, 37 (4) :253 - 261.
  • 5Kennedy R, Celis E. Multiple roles for CD4 + T cells in anti- tumor immune responses [ J 1 hnmunol Rev, 2008, 222 ( 1 ) : 129 - 144.
  • 6Khalilzadeh O, Mojazi Amiri H, Tahvildari M et al. Pretibial myxedema is associated with polymorphism in exon 1 of CTLA-4 gene in patients with Graves' ophthalmopathy[ J]. Arch Dermatol Res, 2009, 301 (10) :719 -723.
  • 7Chen Z, Brant SR, Li C, et al. CTLA4-1661A/G and 3'UTR long repeat polymorphisms are associated with ulcerative colitis and influence CTLA4 mRNA and protein expression[ J ].Genes hnmun, 2010, 11 (7) :573 -583.
  • 8Osei-Hyiaman D, Hou L, Zhiyin R, et al. Association of a novel point mutation(C159G) of the CTLA4 gene with type 1 diabetes in West Africans but not in Chinese [ J ]. Diabetes, 2001,50 (9) :2169 -2171.
  • 9Han Q, Duan S, Zhang G, et al. Associations between cytotoxic T lymphocyte-associaled antigen-4 polymorphisms and serum tumor necrosis factor-α and interferon-y levels in patients with chronic hepatitis B virus infection [ J] .Inflamm Res, 2011, 60 (11) :1071 - 1078.
  • 10Hodi FA, Butler M, Oble DA, ct al. hnmunologie and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients[ J ]. Proc Natl Acad Sci USA, 2008,105 ( 8 ) : 3005 - 3010.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部